CT-95 in Advanced Cancers Associated With Mesothelin Expression

Conditions

• Mesothelin-Expressing Tumors
• Epithelial Ovarian Cancer
• Malignant Pleural Mesothelioma, Advanced
• Malignant Peritoneal Mesothelioma, Advanced
• Pancreatic Adenocarcinoma Advanced or Metastatic
• Lung Adenocarcinoma Metastatic
• Cholangiocarcinoma Advanced
• Cholangiocarcinoma Non-resectable
• Mesothelin-expressing Advanced Cancers
• Mesothelin-positive Advanced Malignant Solid Tumors
• Colorectal Cancer

Interventions

• DRUG: CT-95

Sponsor

Context Therapeutics Inc.